×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Yahoo Finance
BALA CYNWYD, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology...
1 month ago
Larimar Therapeutics Announces Proposed Underwritten Public Offering
GlobeNewswire
BALA CYNWYD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ... In addition, Larimar expects to grant the underwriters a 30-day...
2 months ago
Larimar lays out FDA approval plan for Friedreich's ataxia drug
Clinical Trials Arena
Larimar has reported positive Phase II data and plans to start a confirmatory trial, intending to file a BLA in H2 2025.
2 months ago
Leerink bullish on Larimar Therapeutics, initiates with an Outperform - TipRanks.com
Tipranks
As previously reported, Leerink analyst Joori Park initiated coverage of Larimar Therapeutics with an Outperform rating and $25 price target.
3 weeks ago
LRMR Stock Earnings: Larimar Therapeutics Misses EPS for Q4 2023
InvestorPlace
LRMR stock results show that Larimar Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
1 month ago
Larimar Therapeutics rises after pricing $150M stock offering (NASDAQ:LRMR)
Seeking Alpha
Larimar Therapeutics (LRMR) announces a public offering to raise $150M, driving shares up 11% premarket.
2 months ago
With 45% ownership, Larimar Therapeutics, Inc. (NASDAQ:LRMR) has piqued the interest of hedge funds investors
Yahoo Finance
It looks like hedge funds own 45% of Larimar Therapeutics shares. That catches my attention because hedge funds sometimes try to influence...
4 months ago
Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
GlobeNewswire
14, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ... In addition, Larimar has granted the underwriters a 30-day option to purchase up to an...
2 months ago
Larimar Therapeutics Secures $161.8M from Public Offering - TipRanks.com
Tipranks
Larimar Therapeutics, Inc. (LRMR) has released an update. Larimar Therapeutics, Inc. successfully completed an underwritten public offering...
2 months ago
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the ...
Yahoo Finance
BALA CYNWYD, Pa., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology...
2 months ago